Middle East: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in the Middle East

The Middle Eastern market for other medicaments for therapeutic or prophylactic uses expanded sharply to $X in 2022, growing by X% against the previous year. The total consumption indicated a resilient increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2018 indices. As a result, consumption attained the peak level of $X. From 2016 to 2022, the growth of the market remained at a somewhat lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in the Middle East

In value terms, production of other medicaments for therapeutic or prophylactic uses contracted slightly to $X in 2022 estimated in export price. Overall, production, however, recorded a deep setback. The most prominent rate of growth was recorded in 2017 with an increase of X% against the previous year. As a result, production attained the peak level of $X. From 2018 to 2022, production of growth failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in the Middle East

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after three years of decline. Overall, exports, however, showed a abrupt descent. The volume of export peaked at X tons in 2017; however, from 2018 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022. Over the period under review, exports, however, showed a perceptible contraction. The level of export peaked at $X in 2017; however, from 2018 to 2022, the exports remained at a lower figure.

Exports by Country

Israel prevails in uses structure, accounting for X tons, which was near X% of total exports in 2022. It was distantly followed by Jordan (X tons), generating an X% share of total exports. Turkey (X tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to other medicaments for therapeutic or prophylactic uses exports from Israel stood at X%. At the same time, Turkey (X%) displayed positive paces of growth. Moreover, Turkey emerged as the fastest-growing exporter exported in the Middle East, with a CAGR of X% from 2012-2022. By contrast, Jordan (X%) illustrated a downward trend over the same period. Turkey (X p.p.) and Israel (X p.p.) significantly strengthened its position in terms of the total exports, while Jordan saw its share reduced by X% from 2012 to 2022, respectively.

In value terms, Israel ($X) remains the largest other medicaments for therapeutic or prophylactic uses supplier in the Middle East, comprising X% of total exports. The second position in the ranking was taken by Jordan ($X), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value in Israel stood at X%. In the other countries, the average annual rates were as follows: Jordan (X% per year) and Turkey (X% per year).

Export Prices by Country

In 2022, the export price in the Middle East amounted to $X per ton, growing by X% against the previous year. Export price indicated moderate growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, export price for other medicaments for therapeutic or prophylactic uses increased by X% against 2020 indices. The pace of growth was the most pronounced in 2021 an increase of X% against the previous year. The level of export peaked in 2022 and is expected to retain growth in the immediate term.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Israel ($X per ton), while Turkey ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Jordan (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in the Middle East

In 2022, the amount of other medicaments for therapeutic or prophylactic uses imported in the Middle East fell to X tons, shrinking by X% compared with 2021. In general, imports recorded a noticeable shrinkage. The pace of growth appeared the most rapid in 2013 with an increase of X%. As a result, imports attained the peak of X tons. From 2014 to 2022, the growth of imports of failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses contracted to $X in 2022. Overall, imports recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2019 with an increase of X%. The level of import peaked at $X in 2014; however, from 2015 to 2022, imports remained at a lower figure.

Imports by Country

Turkey was the key importer of other medicaments for therapeutic or prophylactic uses in the Middle East, with the volume of imports reaching X tons, which was approx. X% of total imports in 2022. Saudi Arabia (X tons) held a X% share (based on physical terms) of total imports, which put it in second place, followed by Iran (X%), the United Arab Emirates (X%), Israel (X%), Yemen (X%), Iraq (X%) and Jordan (X%).

Turkey was also the fastest-growing in terms of the other medicaments for therapeutic or prophylactic uses imports, with a CAGR of X% from 2012 to 2022. At the same time, Iran (X%) and Saudi Arabia (X%) displayed positive paces of growth. By contrast, the United Arab Emirates (X%), Yemen (X%), Israel (X%), Jordan (X%) and Iraq (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Turkey, Saudi Arabia and Iran increased by X, X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest other medicaments for therapeutic or prophylactic uses importing markets in the Middle East were Turkey ($X), Saudi Arabia ($X) and Iran ($X), with a combined X% share of total imports.

Iran, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in the Middle East stood at $X per ton in 2022, falling by X% against the previous year. Import price indicated a temperate expansion from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, import price for other medicaments for therapeutic or prophylactic uses increased by X% against 2016 indices. The pace of growth was the most pronounced in 2021 when the import price increased by X%. As a result, import price reached the peak level of $X per ton, and then dropped modestly in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Saudi Arabia ($X per ton), while Yemen ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Jordan (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :